We have located links that may give you full text access.
MRI characteristics of olecranon bursitis.
AJR. American Journal of Roentgenology 2004 July
OBJECTIVE: Our aim was to describe the MRI characteristics of septic and nonseptic olecranon bursitis.
MATERIALS AND METHODS: MRI contrast-enhanced examinations (n = 19) of 35 patients with olecranon bursitis (septic, n = 14; nonseptic, n = 21) were jointly reviewed by two musculoskeletal radiologists. We evaluated bursa size, extent of marginal lobulation, septation, concomitant elbow joint effusion, soft-tissue edema, rim enhancement, soft-tissue enhancement, degree of fluid complexity, definition of bursa margins, presence of edema, thickening of the triceps tendon, and bone marrow edema.
RESULTS: Comparison of septic and nonseptic bursitis yielded the following results: marginal lobulation, 79% (11/14) versus 48% (10/21), p = 0.14; bursa septation, 64% (9/14) versus 57% (12/21), p = 1.0; moderate or marked complexity of bursa fluid, 64% (9/14) versus 29% (6/21), p = 0.15; poorly defined margins, 64% (9/14) versus 67% (14/21), p = 1.0; elbow joint effusion, 86% (12/14) versus 52% (11/21), p = 0.12; moderate to marked soft-tissue edema, 64% (9/14) versus 33% (7/21), p = 0.1; edema of the triceps, 57% (8/14) versus 48% (10/21), p = 0.73; thickening of the triceps, 43% (6/14) versus 14% (3/21), p = 0.21; bone marrow edema, 29% (4/14) versus 5% (1/21), p = 0.13; rim enhancement, 100% (11/11) versus 75% (6/8), p = 0.31; soft-tissue enhancement, 100% (11/11) versus 63% (5/8), p = 0.1.
CONCLUSION: Septic and nonseptic olecranon bursitis present with a considerable overlap of MRI findings without statistically significant differences. Septic olecranon bursitis can be excluded in the absence of bursal and soft-tissue enhancement.
MATERIALS AND METHODS: MRI contrast-enhanced examinations (n = 19) of 35 patients with olecranon bursitis (septic, n = 14; nonseptic, n = 21) were jointly reviewed by two musculoskeletal radiologists. We evaluated bursa size, extent of marginal lobulation, septation, concomitant elbow joint effusion, soft-tissue edema, rim enhancement, soft-tissue enhancement, degree of fluid complexity, definition of bursa margins, presence of edema, thickening of the triceps tendon, and bone marrow edema.
RESULTS: Comparison of septic and nonseptic bursitis yielded the following results: marginal lobulation, 79% (11/14) versus 48% (10/21), p = 0.14; bursa septation, 64% (9/14) versus 57% (12/21), p = 1.0; moderate or marked complexity of bursa fluid, 64% (9/14) versus 29% (6/21), p = 0.15; poorly defined margins, 64% (9/14) versus 67% (14/21), p = 1.0; elbow joint effusion, 86% (12/14) versus 52% (11/21), p = 0.12; moderate to marked soft-tissue edema, 64% (9/14) versus 33% (7/21), p = 0.1; edema of the triceps, 57% (8/14) versus 48% (10/21), p = 0.73; thickening of the triceps, 43% (6/14) versus 14% (3/21), p = 0.21; bone marrow edema, 29% (4/14) versus 5% (1/21), p = 0.13; rim enhancement, 100% (11/11) versus 75% (6/8), p = 0.31; soft-tissue enhancement, 100% (11/11) versus 63% (5/8), p = 0.1.
CONCLUSION: Septic and nonseptic olecranon bursitis present with a considerable overlap of MRI findings without statistically significant differences. Septic olecranon bursitis can be excluded in the absence of bursal and soft-tissue enhancement.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app